JoVE Logo

Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Here, we present a protocol to establish a new rat model of active HIV infection using chimeric HIV (EcoHIV), which is critical for enhancing our understanding of HIV-1 viral reservoirs in the brain and offering a system to study HIV-associated neurocognitive disorders and associated comorbidities (i.e., drug abuse).

Abstract

It has been well studied that the EcoHIV infected mouse model is of significant utility in investigating HIV associated neurological complications. Establishment of the EcoHIV infected rat model for studies of drug abuse and neurocognitive disorders, would be beneficial in the study of neuroHIV and HIV-1 associated neurocognitive disorders (HAND). In the present study, we demonstrate the successful creation of a rat model of active HIV infection using chimeric HIV (EcoHIV). First, the lentiviral construct of EcoHIV was packaged in cultured 293 FT cells for 48 hours. Then, the conditional medium was concentrated and titered. Next, we performed bilateral stereotaxic injections of the EcoHIV-EGFP into F344/N rat brain tissue. One week after infection, EGFP fluorescence signals were detected in the infected brain tissue, indicating that EcoHIV successfully induces an active HIV infection in rats. In addition, immunostaining for the microglial cell marker, Iba1, was performed. The results indicated that microglia were the predominant cell type harboring EcoHIV. Furthermore, EcoHIV rats exhibited alterations in temporal processing, a potential underlying neurobehavioral mechanism of HAND as well as synaptic dysfunction eight weeks after infection. Collectively, the present study extends the EcoHIV model of HIV-1 infection to the rat offering a valuable biological system to study HIV-1 viral reservoirs in the brain as well as HAND and associated comorbidities such as drug abuse.

Introduction

Biological systems have enhanced our understanding of HIV-1 associated neurocognitive disorders (HAND) and their underlying neural mechanisms2. Determining which biological system is most appropriate for any given study is often dependent upon the question of interest2. The limitation of the range of host animal models challenges studies of HIV-1 disease development. To investigate HIV-1 viral replication and pathogenesis, Potash et al.3 created a mouse model of active HIV-1 infection, replacing the coding region of HIV surface envelope glycoprotein, gp120, with ecotropic MLV gp80, which led to successful viral replication in mice4. After tail vein injections in chimeric HIV (EcoHIV) mice, many characteristics were observed resembling those of HIV-1 seropositive individuals (e.g., infected lymphocytes and macrophages, targeted for antiviral immune responses, and inflammation3,5,6).

Although mice and rats are both members of the Muridae, fundamental species differences may influence their suitability for specific experimental questions7. Therefore, the extension of the EcoHIV infection model to rats (commonly used in studies of drug abuse and neurocognitive disorders) would be advantageous in the study of neuroHIV. For example, their larger size makes jugular catheter implantation for drug self-administration procedures more practical8. Drug self-administration techniques in rats have been utilized to evaluate motivation in HIV-19. Furthermore, many neurocognitive/behavioral tasks were initially designed for rats10. Here, we report the utilization of stereotaxic injections of EcoHIV in rats to extend the EcoHIV infection model and afford a key opportunity to address novel questions related to neuroHIV and HAND.

Protocol

All animal protocols were reviewed and approved by the Animal Care and Use Committee at the University of South Carolina (federal assurance number: D16-00028). Six adult male F344/N rat was pair housed in a controlled environment under a 12/12 light: dark cycle with ad libitum access to food and water. All animals were cared for using guidelines established by the National Institutes of Health in the Guide for the Care and Use of Laboratory Animals.

1. Virus packaging in 293 FT cells

  1. Culture the 293 FT cells (5×105/mL) in gelatin coated 75 cm2 flasks with DMEM plus 10% FBS11. Grow cells at 37 °C to be 50% confluent at transfection.
  2. Dilute 22.5 µL of transfection reagent (e.g., Lipofectamine 3000) in 750 µL of medium (e.g., Opti-MEM) in a 1.5 mL micro-centrifuge tube and vortex for 3 s.
  3. Dilute 20 µg of EcoHIV plasmid DNA in 750 µL of medium in a 1.5 mL micro-centrifuge tube and mix well.
  4. Add diluted DNA into the tube of diluted transfection reagent and mix gently. Incubate for 15 min at room temperature.
  5. Add the mixture to 10 mL of prewarmed DMEM medium in 75 cm2 flask. Incubate cells for 2 days at 37 °C.
  6. Harvest and combine 24 mL of conditional medium from the two flasks that include the packaged lentivirus.
  7. Centrifuge all 24 mL of conditional medium at 500 x g for 10 minutes at 4 °C. Transfer the clarified supernatant to a sterile 50 mL tube.
  8. Combine 8 mL of Lenti-x concentrator with 24 mL of clarified supernatant (1:3 ratio). Mix by gentle inversion. Incubate mixture at 4 °C for two days.
  9. Centrifuge mixture at 1,500 x g for 45 minutes at 4 °C. Carefully remove the supernatant.
  10. Gently re-suspend the pellet with 100 µL of 100 mM PBS.
  11. Titer virus concentration with a p24 ELISA kit.

2. EcoHIV-EGFP virus stereotaxic surgeries

  1. Anesthetize rats using 3% sevoflurane. Proceed to step 2.2 when the rats are not responsive to noxious stimuli and reflexes are absent.
  2. Shave the hairs from the brain region and sterilize the skin twice with 70% ethanol and a chlorhexidine-based scrub. Secure the rat in a prone position in the stereotaxic apparatus.
  3. Make an incision (5-6 cm) through the skin along the scalp midline.
  4. Mark two drilling positions at 0.8 mm lateral, 1.2 mm rostral to bregma. Drill a hole (diameter 0.4 mm) in each skull position.
  5. Fill titered EcoHIV lentivirus solution (1.04 × 106 TU/mL) in a 10 µL injection syringe. Secure the syringe to the stereotaxic apparatus.
  6. Move down the needle close to the surface of drilling hole. Measure and move 2.5 mm in depth.
  7. Infuse 1 µL of virus solution at a rate of 0.2 µL/min. Keep the needle inside of the injection area for 5 min. Slowly move the needle up until it is outside of the rat skull.
  8. Suture the skin with a 4-0 silk thread.
  9. Sterilize the incision with 70% ethanol once. Subcutaneously inject butorphenol (Dorolex, 0.1 mg/kg body weight).
  10. Transfer the rat to a recovery chamber with a heating pad until it wakes up.

3. Visualization of brain sections

NOTE: Wait one to eight weeks after EcoHIV viral infusion.

  1. Anesthetize the rat with 5% sevoflurane. Continue to step 3.2 when the rats are not responsive to noxious stimuli and reflexes are absent.
  2. Fix the rat in a supine position inside a fume hood.
  3. Incise the skin along the thoracic midline. Cut the diaphragm and open the thoracic cavity.
  4. Insert a 20 G × 25 mm needle into the left ventricle.
  5. Immediately open the right atrium with scissors.
  6. Perfuse 50 mL of prechilled 100 mM PBS at a rate of 5 mL/min.
  7. Perfuse 100 mL of cold 4% paraformaldehyde at a rate of 5 mL/min.
  8. Decapitate the rat, open the scalp and remove the brain.
  9. Postfix overnight with 4% paraformaldehyde.
  10. Transfer the brain to 40 mL of 30% sucrose in 100 mM PBS in 50 mL tube until the brain floats down to the bottom (about 3 days).
  11. Snap freeze the brain in methylbutanol for 2 min at - 80 °C.
  12. Secure the brain tissue on a metal platform inside a -20 °C cryostat.
  13. Cut 50 µm thick coronal sections using the cryostat.
  14. Transfer the brain slices onto glass slides with a fine brush.
  15. Mount sections in 0.3 mL of antifade medium and cover with 22 mm 50 mm coverslips.
  16. Keep the glass slides in the dark at room temperature till dry.
  17. Image the targeted neurons with a confocal microscope using Z-stack based on brain region boundaries and morphological characteristics of neurons.
    NOTE: The confocal microscope settings used were: magnification of 60 X (A/1.4, oil), and a Z-plane interval of 0.15 µm (pinhole size 30 µm; back-projected pinhole radius 167 nm) using a wavelength of 488 nm.

Results

The conditioned medium was collected from lentivirus of EcoHIV-EGFP infected 293FT cells. Next, it was concentrated and titered, then stereotaxically injected into the brain (cortical region) of F344/N rats. Seven days post-injection, rats were sacrificed and images were taken from coronal brain slices ranging from bregma 5.64 mm to bregma -4.68 mm. In Figure 1A, there are significant EcoHIV-EGFP signals throughout the brain, especially in the cortex and the hippocampal dentate gyrus. Furthe...

Discussion

In this protocol, we established an EcoHIV-induced HIV infection model in rats. Specifically, we described a bilateral stereotaxic injection of EcoHIV into the cortex which successfully induced active HIV infection in the rat brain 7 days post-injection. Futhermore, we demonstrate that EcoHIV infection in rats could be a good biological system to study key aspects of HAND. Eight weeks post- EcoHIV infection, rats exhibited significant neurocognitive impairments, which included the alterations in temporal processing and s...

Disclosures

None of the authors have conflicts of interest to declare.

Acknowledgements

This work was funded by NIH grants HD043680, MH106392, DA013137, and NS100624.

Materials

NameCompanyCatalog NumberComments
293FT cellsThermoFisher ScientificR70007
Antibiotic-Antimycotic solutionCellgro30004CI100X
Corning BioCoatGelatin 75cm² Rectangular Canted Neck Cell Culture Flask with Vented CapLife Technologies354488
Corning DMEM with L-Glutamine, 4.5 g/L Glucose and Sodium PyruvateLife Technologies10013CV
Cover glassVWR637-137
drill
Dumont #5 ForcepsWorld Precision Instruments14095
Dumont #7 ForcepsWorld Precision Instruments14097
Eppendorf Snap-Cap Microcentrifuge Biopur Safe-Lock TubesLife Technologies22600028
Ethicon Vicryl Plus Antibacterial, 4-0 Polyglactin 910 Suture, 27in. FS-2Med Vet InternationalVCP422H
Hamilton syringeHamilton1701
Invitrogen Lipofectamine 3000 Transfection ReagentLife TechnologiesL3000015
Iris ForcepsWorld Precision Instruments15914
Iris ScissorsWorld Precision Instruments500216
Lentivirus-Associated p24 ELISA KitCell Biolabs, inc.VPK-107-5
Lenti-X ConcentratorTakaraPT4421-2
Opti-MEM I Reduced Serum MediumLife Technologies11058021
ParaformaldehydeSigma-Aldrich158127-500G
ParaformaldehydeSigmaP6148
ProLong GoldFisher ScientificP36930
SevofluraneMerritt Veterinary Supply347075
stereotaxic apparatusKopf InstrumentsModel 900
SuperFrost Plus SlidesFisher Scientific12-550-154%
Vannas ScissorsWorld Precision Instruments500086

References

  1. Illenberger, J. M., et al. HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History. Journal of Neuroimmune Pharmacology. 15 (4), 715-728 (2020).
  2. Joseph, S. B., Swanstrom, R. The evolution of HIV-1 entry phenotypes as a guide to changing target cells. Journal of Leukocyte Biology. 103 (3), 421-431 (2018).
  3. Potash, M. J., et al. A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness. Proceedings of the National Academy of Sciences U S A. 102 (10), 3760-3765 (2005).
  4. Albritton, L. M., Tseng, L., Scadden, D., Cunningham, J. M. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell. 57, 659-666 (1989).
  5. Geraghty, P., Hadas, E., Kim, B. H., Dabo, A. J., Volsky, D. J., Foronjy, R. HIV infection model of chronic obstructive pulmonary disease in mice. American Journal of Physiology - Lung Cellular and Molecular Physiology. 312 (4), 500-509 (2017).
  6. Gu, C. J., et al. EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment. PLoS Pathogens. 14 (6), 1007061 (2018).
  7. Ellenbroek, B., Youn, J. Rodent models in neuroscience research: is it a rat race. Disease Models, Mechanisms. 9 (10), 1079-1087 (2016).
  8. Feduccia, A. A., Duvauchelle, C. L. Novel apparatus and method for drug reinforcement. Journal of Visualized Experiments. (42), e1998 (2010).
  9. Bertrand, S. J., Mactutus, C. F., Harrod, S. B., Moran, L. M., Booze, R. M. HIV-1 proteins dysregulate motivational processes and dopamine circuitry. Scientific Reports. 8 (1), 7869 (2018).
  10. McGaughy, J., Sarter, M. Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology. 117 (3), 340-357 (1995).
  11. Li, H., Aksenova, M., Bertrand, S., Mactutus, C. F., Booze, R. M. Quantification of filamentous actin (F-actin) puncta in rat cortical neurons. Journal of Visualized Experiments. (108), (2016).
  12. McLaurin, K. A., Li, H., Booze, R. M., Mactutus, C. F. Disruption of Timing: NeuroHIV Progression in the Post-cART Era. Scientific Reports. 9 (1), 827 (2019).
  13. McLaurin, K. A., Moran, L. M., Li, H., Booze, R. M., Mactutus, C. F. The Power of Interstimulus Interval for the Assessment of Temporal Processing in Rodents. Journal of Visualized Experiments. (146), e58659 (2019).
  14. Li, H., McLaurin, K. A., Mactutus, C. F., Booze, R. M. Ballistic Labeling of Pyramidal Neurons in Brain Slices and in Primary Cell Culture. Journal of Visualized Experiments. (158), (2020).
  15. Ko, A., et al. Macrophages but not Astrocytes Harbor HIV DNA in the Brains of HIV-1-Infected Aviremic Individuals on Suppressive Antiretroviral Therapy. Journal of Neuroimmune Pharmacology. 14 (1), 110-119 (2019).
  16. Sopper, S., et al. The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from rhesus monkey. Virology. 220 (2), 320-329 (1996).
  17. Llewellyn, G. N., Alvarez-Carbonell, D., Chateau, M., Karn, J., Cannon, P. M. HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency. Journal of NeuroVirology. 24 (2), 192-203 (2018).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

EcoHIVRat ModelHIV InfectionChimeric HIVNeurocognitive DisordersDrug AbuseNeuro HIVTransfection Reagent293 T cellsLenti X ConcentratorP24 ELISA KitStereotaxic Apparatus

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved